GSK Plc (GSK)
51.78
-0.63
(-1.20%)
USD |
NYSE |
Aug 24, 16:00
51.79
+0.01
(+0.02%)
After-Hours: 20:00
GSK Total Liabilities (Quarterly) : 59.14B for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.14B |
| March 31, 2026 | 59.93B |
| December 31, 2025 | 60.75B |
| September 30, 2025 | 61.37B |
| June 30, 2025 | 61.53B |
| March 31, 2025 | 60.73B |
| December 31, 2024 | 58.08B |
| September 30, 2024 | 59.82B |
| June 30, 2024 | 55.99B |
| March 31, 2024 | 57.20B |
| December 31, 2023 | 58.91B |
| September 30, 2023 | 58.88B |
| June 30, 2023 | 60.14B |
| March 31, 2023 | 58.46B |
| December 31, 2022 | 60.21B |
| September 30, 2022 | 57.60B |
| June 30, 2022 | 80.65B |
| March 31, 2022 | 65.90B |
| December 31, 2021 | 78.23B |
| September 30, 2021 | 76.78B |
| June 30, 2021 | 76.58B |
| March 31, 2021 | 78.74B |
| December 31, 2020 | 81.50B |
| September 30, 2020 | 77.96B |
| June 30, 2020 | 79.70B |
| Date | Value |
|---|---|
| March 31, 2020 | 79.71B |
| December 31, 2019 | 81.25B |
| September 30, 2019 | 80.33B |
| June 30, 2019 | 77.21B |
| March 31, 2019 | 76.87B |
| December 31, 2018 | 69.28B |
| September 30, 2018 | 71.57B |
| June 30, 2018 | 72.10B |
| March 31, 2018 | 73.74B |
| December 31, 2017 | 71.55B |
| September 30, 2017 | 72.39B |
| June 30, 2017 | 69.90B |
| March 31, 2017 | 67.08B |
| December 31, 2016 | 66.87B |
| September 30, 2016 | 71.17B |
| June 30, 2016 | 71.39B |
| March 31, 2016 | 68.90B |
| December 31, 2015 | 65.69B |
| September 30, 2015 | 66.33B |
| June 30, 2015 | 68.52B |
| March 31, 2015 | 69.16B |
| December 31, 2014 | 55.69B |
| September 30, 2014 | 56.02B |
| June 30, 2014 | 54.74B |
| March 31, 2014 | 53.81B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 66.63B |
| Eli Lilly & Co. | 108.40B |
| Merck & Co., Inc. | 87.82B |
| Pfizer Inc. | 115.64B |
| Sanofi | -- |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 81.94B |
| Shareholders Equity (Quarterly) | 23.42B |
| Debt to Equity Ratio | 1.034 |
| Current Ratio | 0.8154 |
| Net Debt Paydown Yield | -0.08% |